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Abstract
Background: Adverse health effects at relatively low levels of ambient air pollution have consistently been
reported in the last years. We conducted a time-series panel study of subjects with chronic obstructive pulmonary
disease (COPD), asthma, and ischemic heart disease (IHD) to evaluate whether daily levels of air pollutants have
a measurable impact on the lung function of adult subjects with pre-existing lung or heart diseases.
Methods:  Twenty-nine patients with COPD, asthma, or IHD underwent repeated lung function tests by
supervised spirometry in two one-month surveys. Daily samples of coarse (PM10–2.5) and fine (PM2.5) particulate
matter were collected by means of dichotomous samplers, and the dust was gravimetrically analyzed. The
particulate content of selected metals (cadmium, chrome, iron, nickel, lead, platinum, vanadium, and zinc) was
determined by atomic absorption spectrometry. Ambient concentrations of nitrogen dioxide (NO2), carbon
monoxide (CO), ozone (O3), and sulphur dioxide (SO2) were obtained from the regional air-quality monitoring
network. The relationships between concentrations of air pollutants and lung function parameters were analyzed
by generalized estimating equations (GEE) for panel data.
Results: Decrements in lung function indices (FVC and/or FEV1) associated with increasing concentrations of
PM2.5, NO2 and some metals (especially zinc and iron) were observed in COPD cases. Among the asthmatics,
NO2 was associated with a decrease in FEV1. No association between average ambient concentrations of any air
pollutant and lung function was observed among IHD cases.
Conclusion: This study suggests that the short-term negative impact of exposure to air pollutants on respiratory
volume and flow is limited to individuals with already impaired respiratory function. The fine fraction of ambient
PM seems responsible for the observed effects among COPD cases, with zinc and iron having a potential role via
oxidative stress. The respiratory function of the relatively young and mild asthmatics included in this study seems
to worsen when ambient levels of NO2 increase.
Published: 05 May 2006
Environmental Health: A Global Access Science Source 2006, 5:11 doi:10.1186/1476-069X-5-
11
Received: 04 July 2005
Accepted: 05 May 2006
This article is available from: http://www.ehjournal.net/content/5/1/11
© 2006 Lagorio et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Environmental Health: A Global Access Science Source 2006, 5:11 http://www.ehjournal.net/content/5/1/11
Page 2 of 12
(page number not for citation purposes)
Background
Throughout the 1990s, many epidemiological studies
consistently reported adverse health effects at unexpect-
edly low levels of ambient air pollution [1]. Identification
of susceptible sub-populations and mechanisms of effect
involved are two clear research priorities [2,3]. Several
chronic clinical conditions are good candidates to define
the "frail" population susceptible to the acute effects of
PM pollution: chronic obstructive pulmonary disease
(COPD) including asthma, ischemic heart diseases
(IHD), congestive heart failure, heart rhythm disorders,
and diabetes [4].
The mechanisms of lung injury caused by particles among
people with COPD have been reviewed [5]. The ability of
particulate matter to induce oxidative stress in the airways
has been proposed as an important biological mechanism
[6]. The oxidative stress mediated by particles may arise
from direct generation of reactive oxygen species from the
surface of particles or from soluble compounds such as
transition metals or organic compounds (poly-aromatic
hydrocarbons) [7]. Oxidative stress might up-regulate
redox sensitive transcription factors (via nuclear factor
kappa B, NF-kB) in airway epithelial cells, thus increasing
the synthesis of proinflammatory cytokines and resulting
in cell and tissue injury [8].
In healthy and asthmatic volunteers, airborne particles
increase bronchial responsiveness, airway resistance, and
bronchial tissue mast cell, neutrophil, and lymphocyte
counts [9]. A specific role for ultrafine particles and metal-
lic content of PM (especially iron) has been advocated
[10,11].
The relationship between daily levels of air pollutants and
respiratory function in patients with chronic respiratory
diseases has been analyzed in various panel studies, with
inconsistent results [12,13]. Most studies concern asth-
matic children, while far fewer observations relate to
changes in peak expiratory flow rate [14-22] or in spiro-
metric flow and volume [23-26] among adult or elderly
asthmatics or COPD patients.
We conducted a time-series panel study of subjects with
COPD, asthma, and IHD with the aim of answering the
following question: have daily fluctuations of selected air
pollutants a measurable impact on the lung function of
subjects with pre-existing lung or heart disease?
Methods
Participant recruitment
Study subjects were selected among outpatients of the
Pneumology and Cardiology Departments of the Catholic
University Hospital in Rome (UCSC) included in routine
clinical follow-up programs. Eligible for the study were
residents of Rome, living in census tracts less than 2 km
away from one of the six air monitoring stations consid-
ered in this study.
A number of clinical criteria was specified for each noso-
logical category. Eligibility for the COPD panel included
age from 50 to 80 years, a ratio of forced expiratory vol-
ume in one second to forced vital capacity (FEV1/FVC) less
than 60%, partial oxygen pressure (SpO2) at arterial blood
oximetry = 60–70 mmHg, normal values of carboxyhe-
moglobin (COHb), normal acid-base balance, no con-
comitant IHD, no need of oxygen therapy or breathing
apparatus, no pacemaker, no cardiac arrhythmias, diabe-
tes, Parkinson disease or chronic alcohol abuse, and no
use of either psycho-chemical drugs or long acting bron-
chodilators; occasional use of short-acting bronchodila-
tors was allowed.
Admittance to the asthmatic panel was allowed to subjects
aged 18 to 64 years, positive at the bronchial reactivity test
by hypertonic saline solution, with disease in the mild
intermittent stage [27]. Occasional use of β-adrenergic
stimulants was allowed, but assumption of steroids or
other asthma-preventive drugs (either before, or during
the study periods) was not.
Participation in the IHD panel was restricted to subjects
aged 40 to 64 years, with stable angina or previous myo-
cardial infarction (at least 1 year prior to recruitment), no
concomitant COPD, no use of calcium channel blockers,
no pacemaker, no atrial fibrillation (other arrhythmias
admitted), diabetes, Parkinson disease or chronic alcohol
abuse, and no use of psycho-chemical drugs.
In relation to smoking habits, participation in the asth-
matic panel was restricted to never smokers. Never smok-
ers, however, were almost absent from the clinical series
of COPD and IHD outpatients; former smokers were then
admitted to the COPD and IHD panels if they had given
up smoking at least 1 year before enrollment (sustained
quitters).
The study protocol was approved by the Ethical Commit-
tee of the UCSC. Twenty-nine patients with COPD (7 men
and 4 women), asthma (5 men and 6 women) or IHD (6
men and 1 woman) gave their written informed consent
to undergo repeated clinical examinations for two one-
month periods, in the spring and winter of 1999.
Study time period
The time period of interest consisted of 67 days in total,
from 24 May to 24 June and from 18 November to 22
December 1999. These periods were chosen based on his-
torical time series analyses of air pollution levels in Rome,
due to their high variability in air pollutant concentrations.Environmental Health: A Global Access Science Source 2006, 5:11 http://www.ehjournal.net/content/5/1/11
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Health monitoring
Study subjects were scheduled to be examined three days
apart, at home (COPD and IHD panels) or at the Pneu-
mology Clinic of the UCSC (asthmatic panel). Forced
vital capacity (FVC) and forced expiratory volume in 1 sec-
ond (FEV1) were measured by spirometry. Spirometries
were supervised, and done with the subject in a sitting
position and wearing a nose-clip, following the sugges-
tions of the American Thoracic Society [28]. Spirometries
were always done in the afternoon (between 4 pm and 8
pm), at least 6 hours after a possible inhalation of short-
acting bronchodilators. A heated Fleish tube n. 3 portable
spirometer (Biomedin, Italy) was used in the COPD and
IHD panels, and a light bell Stead-Wells spirometer (Bio-
medin, Italy) in the asthmatic group. Between instru-
ments reproducibility, for both FVC and FEV1, was within
30 ml and the calibration procedures were regularly per-
formed [28]. Pulmonary function indices used in the
analyses are expressed as the percentage of the predicted
values based on the subject- specific sex, age, height and
weight [29].
Only amongst asthmatics we determined concentrations
of nitric oxide (NO) in exhaled breath, an indicator of
bronchial inflammation [30], using the analyzer model
280 (Sievers Instruments, USA). Subjects were breathing
NOx free air prior to this test. Asthmatics were also asked
to fill in a brief daily questionnaire collecting information
about the occurrence of asthma attacks and β-2 agonist
inhalations.
Study subjects' characteristics
Table 1 describes the characteristics of subjects at entry
and the group-distribution of the outcome variables. As
expected on the basis of the eligibility criteria, asthmatics
were younger than COPD and IHD patients, and the
group average values of FVC and FEV1 were sensibly lower
among COPD cases compared to both IHD and asthmatic
subjects. Overall, the 29 study subjects underwent a total
of 449 spirometries. Due to dropouts, a variable number
of observations per case was available. The average
number of repeated observations was 15 in the COPD
panel (ranging from 1 to 32 per subject), 24 in the IHD
panel (from 12 to 32 per case), and 9 among the asthmat-
ics (from 6 to 18 per person). All IHD patients were regu-
larly treated with aspirin, statins and nitrates. No COPD
or IHD patient made use of bronchodilators (short- or
long-acting) during the survey periods, while 7 out of 11
asthmatics reported β-2 stimulant inhalations on one or
more of the clinical monitoring days. As to previous
smoking habits, all COPD patients were sustained quit-
ters, all asthmatics were never smokers, while in the IHD
panel the five male patients were sustained quitters and
the single female participant was a never smoker.
Environmental data
Mean daily temperature (T, Celsius), barometric pressure
(BarP, mmHg) and relative humidity (RelHum, %) were
available from the Rome weather station (Collegio
Romano – Ufficio Centrale di Ecologia Agricola). The
Department of Environment of the Latium Region pro-
vided us with hourly concentrations of nitrogen dioxide
(NO2), carbon monoxide (CO), ozone (O3), and sulphur
Table 1: Characteristics of study subjects and group averages of lung function parameters over the survey periods
Panel
COPD Asthma IHD
Variable (unit) Gender Obs Mean SD Obs Mean SD Obs Mean SD
Age (years) Male 7 67 11 5 33 15 6 63 11
F e m a l e 46 57 64 8 1 016 4-
Total 11 67 9.1 11 41 14 7 64 10
BMI (kg/m2) Male 7 27 6 5 25 4 6 26 3
F e m a l e 42 53 62 33 12 9-
Total 11 26 5 11 24 3 7 26 3
FVC (% predicted) Male 108 63 10 38 113 11 139 81 10
Female 63 61 9 70 116 12 31 80 4
Total 171 63 10 108 115 12 170 81 9
FEV1 (% predicted) Male 108 45 10 38 94 13 139 84 10
Female 63 47 10 70 96 18 31 84 5
Total 171 45 10 108 95 16 170 84 10
NO in exhaled breath (ppb) Male 37 66 40
Female 70 42 27
Total 107 50 34Environmental Health: A Global Access Science Source 2006, 5:11 http://www.ehjournal.net/content/5/1/11
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dioxide (SO2) recorded at the fixed sites for air-quality
monitoring in Rome. These sites are equipped with con-
tinuous inlet samplers. NO2 is determined by chemilumi-
nescence, CO by IR absorption, O3 by UV absorption, and
SO2 by UV fluorescence.
We computed daily city means (24 h values, from 3 pm to
3 pm of the following day) based on data from varying
type and number of sites, depending on the pollutant. For
NO2 and CO, we calculated 24 h values from five fixed
sites, three of which are located in densely populated areas
in the center of Rome (Magna Grecia, Fermi, Libia) and
two representing background areas (Preneste and Villa
Ada). For O3, concentrations recorded at two background
fixed sites (Preneste and Villa Ada) were used. For SO2, we
used 24 h concentrations recorded at one urban site
(Fermi) and one background site (Villa Ada). The NO2
and SO2 series were complete, while average daily concen-
trations for one single day were missing for CO and O3.
As to particulate matter, we could not use data from the
Rome air-quality monitoring network, because PM2.5 was
not routinely measured. Therefore, for the specific pur-
poses of this survey, 24 h concentrations of PM10–2.5 and
PM2.5 were measured at two selected fixed monitoring
sites: Villa Ada and Istituto Superiore di Sanità (ISS).
These sites, located about 3.5 km apart, were chosen
because, based on historical PM10 monitoring data, are
considered representative of low and high traffic areas in
Rome, respectively. Air samples were collected by means
of dichotomous samplers (Graseby Andersen, model SA
241) operating at 16.7 L/min, with an omni-directional
aerosol inlet. This sampler has been designated as refer-
ence for PM10 by US EPA [31]. Sampling was carried out
from 3 pm to 3 pm of the following day (in order to match
the spirometry time schedule). Sixty-two 24 hour samples
were collected, with 5 missing observations at the begin-
ning of the winter survey. The dust on the couple of
sequential polytetrafluoroethylene (PTFE) filters
(polymethylpentane ringed, 2.0 µm pore size, 37 mm
diameter; Gelman, USA) was gravimetrically analyzed to
obtain average daily concentrations of PM2.5 and PM10–2.5.
PM10 concentrations were calculated by adding the con-
centrations of the sampled fine and coarse fractions. The
averages of PM concentrations measured at the two loca-
tions were used in the statistical analyses, as our best esti-
mate of 24 h mean ambient concentrations for the Rome
neighborhoods the panel participants lived in.
In the PM10–2.5 and PM2.5 samples, the content of selected
metals (cadmium – Cd, chromium – Cr, iron – Fe, nickel
– Ni, lead – Pb, platinum – Pt, vanadium-V, and zinc –
Zn) was determined by atomic absorption spectrometry
(AAS). The concentrations used in the analysis were calcu-
lated as the ratio of the metal amount in each PM sample
to the air volume collected during the sampling.
As a side validation study, we measured indoor PM2.5 con-
centrations in a total of five homes of three study subjects
per survey. COPD cases were preferentially selected for the
side study due to their reduced mobility in comparison
with asthmatics and IHD patients. Participation in the
side validation study was burdensome to the study sub-
jects: a technician had to come every day to change the
sampler filter, and the sampler itself was noisy. Thus, we
only succeeded in getting consent to participate from one
IHD patient for both surveys, and from four COPD cases,
for only one survey each. Participants in the side study
were representative of the full study group in terms of
housing typology (all lived in apartment buildings), floor
[basement, first floor (two homes), second floor, fifth
floor], and distance from the ISS or Villa Ada PM2.5 mon-
itoring sites (varying from 0.3 to 5 km). Indoor 24 h air
samples were collected on 59 days (from 28 May to 24
June and from 22 November to 22 December 1999) by
Micro-Environmental Monitors (SKC, model 400) with a
single-stage impactor, operating at a sampling flow rate of
10 L/min and equipped with a PM2.5 sampling inlet and
PTFE filters (polymethylpentane ringed, 2.0 µm pore size,
37 mm diameter; Gelman, USA). Indoor PM2.5 mass con-
centrations were gravimetrically determined. The 24 h
average concentrations of PM2.5from three homes per sur-
vey were used in the reproducibility analysis.
In a previous inter-method reliability study of PM10 meas-
urements in outdoor and indoor air samples in Rome,
based on two series of 12 parallel 24 h samples, a very
good correlation between MEM and dichotomous sam-
plers was observed (regression 1: y = 1.192x-3.275 - R2 =
0.9506; regression 2: y = 0.998x-1.332 - R2 = 0.9866) [32].
According to the European Standard EN 12341 criteria
[33], the observed values of the determination coefficients
are such that the MEM can be considered equivalent to the
dichotomous sampler.
Statistical analyses
Correlations among outdoor pollutant levels, as well as
those between indoor and outdoor PM2.5 concentrations,
were evaluated by non-parametric tests (Spearman corre-
lation coefficient) applied to variables in the original
scale.
Outcome variables in each panel had observations miss-
ing, and there was unequal spacing (the interval between
observations was not constant). There were a few missing
observations in the exposure variables also (1 missing
daily mean for both O3 and CO concentrations, and 5
missing daily means for PM2.5 and PM10–2.5). MissingEnvironmental Health: A Global Access Science Source 2006, 5:11 http://www.ehjournal.net/content/5/1/11
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observations, in the exposure or outcome variables, were
not replaced with estimates.
The relationships between respiratory function indices
and concentrations of air pollutants were analyzed using
generalized estimating equations (GEE) for panel data
[34]. An autoregressive correlation matrix of lag 1 was
assumed, in order to account for possible correlations
between repeated measures on the same subject. The sta-
tistical package STATA [35] was used for the analyses
(XTGEE; the option "force" was specified in order to allow
for unequally spaced observations). All the linear models
included the within-subject between-period effect, using
the dichotomous season variable (spring and winter). For
the COPD and IHD panels, terms for daily mean temper-
ature (°C), relative humidity (%) and day of the week
(weekday/weekend) were included in the regression mod-
els. For the asthmatics panel, temperature and humidity
terms were included in the regression models along with
β-2 agonist use (yes/no), while the dummy variable week-
day/weekend was not, because only 8 out of 108 spiro-
metries were done on Saturday and none on Sunday. We
considered the possibility of a non-linear effect of temper-
ature by introducing a temperature-squared term in the
regression models; however, since no evidence of model
improvement was found in any of the panel-specific anal-
yses, only a linear term was left. The daily variability of
pulmonary function was examined with respect to the
mean pollutant concentrations of the previous 24 hours
and to the cumulative exposures over the previous 48 and
72 hours. Results from the analyses of lung function indi-
ces are reported as changes in percentage of predicted val-
ues per 10 µg/m3 increase in pollutant concentrations
(except for CO where the unit increase is 1 mg/m3). In
order to assess the relative effects of metals, we report
changes in lung function per interquartile range of
increasing concentrations.
Results
Air pollutant concentrations
The distribution of environmental variable levels (pollut-
ants and weather conditions) during the study period is
described in Table 2. Average daily concentrations of both
PM10 and PM2.5 were higher and more variable from day
to day in winter than in spring. The two PM fractions did
not exceed 123 µg/m3 and 100 µg/m3, respectively. The 24
h NO2 city means did not show statistically significant dif-
ferences by season. The daily variability of CO concentra-
tions, on the contrary, was sensibly higher during the
winter than in spring survey. As expected, outdoor O3 lev-
els were higher and more variable during the spring sur-
vey, but never exceeded 100 µg/m3. Average 24 h
concentrations of SO2 were low and showed little variabil-
ity both in spring and winter. We decided, therefore, a pri-
Table 2: Concentrations of PM, metals from PM2.5, gaseous pollutants, and climatic conditions (1999 spring and winter)
Variable Unit Spring Winter Overall
Obs Mean SD GMean IQR Obs Mean SD GMean IQR Mean SD GMean Min Max IQR
PM2.5* µg/m3 32 18.2 5.0 17.4 8.1 30 36.7 24.1 27.8 40.9 27.2 19.4 21.8 4.5 100 22.7
PM10–2.5 * µg/m3 32 18.7 7.4 17.4 9.0 30 12.3 5.4 11.0 8.3 15.6 7.2 14.0 3.4 39.6 7.1
PM10 * µg/m3 32 36.9 10.8 35.4 13.1 30 49.0 28.1 40.2 45.3 42.8 21.8 37.6 7.9 123 26.9
Cd ng/m3 30 0.29 0.09 0.27 0.14 30 0.63 0.50 0.47 0.47 0.46 0.40 0.36 0.09 2.0 0.31
Cr ng/m3 30 0.90 0.47 0.80 0.61 30 2.8 2.0 2.2 2.7 1.9 1.7 1.3 0.2 9.8 1.6
Fe ng/m3 30 339 180 303 212 30 227 132 190 208 283 167 240 54.1 893 202
Ni ng/m3 30 5.1 4.7 3.6 4.2 30 4.6 8.0 2.7 2.5 4.8 6.5 3.1 1.0 42.3 2.8
Pb ng/m3 30 24.4 9.6 22.2 15.6 30 36.8 23.8 27.7 33.5 30.6 19.0 24.8 2.2 99.8 19.9
Pt pg/m3 30 5.3 6.8 3.3 3.9 30 4.6 10.3 1.4 2.7 5.0 8.6 2.2 0.05 54.9 3.3
V ng/m3 30 2.4 1.6 2.0 2.0 30 1.1 0.52 0.95 0.97 1.8 1.4 1.4 0.47 6.3 1.3
Zn ng/m3 30 28.7 13.0 26.4 15.1 30 63.0 38.2 51.4 58.0 45.8 33.1 36.8 13.9 159 32.9
NO2 
† µg/m3 32 76.1 13.6 75.0 17.5 35 65.5 13.3 64.0 14.6 70.6 14.4 69.0 27.6 102 20.9
CO† mg/m3 32 2.1 0.3 2.1 0.50 34 12.3 4.9 11.5 6.1 7.4 6.2 5.0 1.6 28.9 10.5
O3 
‡ µg/m3 32 70.9 12.5 69.8 16.9 34 16.0 8.1 14.3 10.0 42.6 29.5 30.8 6.6 95.3 58.7
SO2 
‡ µg/m3 32 4.7 1.8 4.3 2.5 35 7.9 2.2 7.6 3.9 6.4 2.6 5.8 1.2 11.6 4.0
T °C 32 23.7 1.9 23.7 3.3 35 9.5 2.1 9.3 2.7 16.3 7.4 14.5 5.3 27.0 14.3
RelHum % 32 46.5 10.2 45.4 14.0 35 66.7 13.5 65.1 14.0 57.0 15.7 54.8 29.0 87.0 24.0
BarP mm 
Hg
32 762 2.6 762 3.4 35 762 7.3 762 12.1 762 5.5 762 748 773 6.6
PM2.5 
Indoor§
µg/m3 28 24.7 7.8 23.7 9.0 31 27.0 12.0 24.4 18.8 25.9 10.2 24.1 10.2 56.5 14.4
*Averages of 24 h concentrations measured at 2 locations.
†Averages of 24 h concentrations recorded at 5 fixed sites.
‡Averages of 24 h concentrations recorded at 2 fixed sites.
§Averages of 24 h concentrations measured at 3 study participants' homes per season.Environmental Health: A Global Access Science Source 2006, 5:11 http://www.ehjournal.net/content/5/1/11
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ori not to consider SO2 further in the analyses. Similarly,
we did not include mean daily values of barometric pres-
sure (BarP) in the regression models, due to its negligible
daily variability.
In terms of relative concentrations, six out of 8 metals
examined were more represented in the fine than in the
coarse fraction of outdoor PM; therefore only metal con-
centrations from the PM2.5 fraction are reported in Table
2. Fe, Zn and Pb were present in sizeable concentrations
Table 3: Correlations among pollutants and weather variables
PM2.5 PM10–25 PM10 NO2 O3 CO SO2 T RelHum BarP
PM2.5 1
PM10–25 0.34 1
PM10 0.93 0.61 1
NO2 0.43 0.51 0.45 1
O3 -0.51 0.31 -0.36 0.17 1
CO 0.67 -0.09 0.55 0.05 -0.87 1
SO2 0.34 -0.16 0.21 0.01 -0.61 0.65 1
T -0.31 0.56 -0.10 0.36 0.79 -0.74 -0.56 1
RelHum 0.17 -0.37 0.06 -0.36 -0.62 0.54 0.43 -0.48 1
BarP 0.65 0.24 0.56 0.47 -0.15 0.28 0.18 -0.15 -0.17 1
Scatter plot of ambient* PM2.5 and indoor** concentrations (µg/m3, by season† and home‡ Figure 1
Scatter plot of ambient* PM2.5 and indoor** concentrations (µg/m3), by season† and home‡ *Averages of PM2.5 24 
h concentrations (µg/m3) at two sites (Villa Ada and ISS). **PM2.5 24 h indoor concentrations (µg/m3) in each home participat-
ing in the side validation study. †Spring = 1 and Winter = 2. ‡1 to 5.Environmental Health: A Global Access Science Source 2006, 5:11 http://www.ehjournal.net/content/5/1/11
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in outdoor PM2.5 samples, whereas Pt, Cd, V, Cr and Ni
were only present in traces.
Correlations among ambient variables are reported in
Table 3. Outdoor concentrations of fine (PM2.5) and
coarse (PM10–2.5) particulate matter were weakly corre-
lated. Daily mean levels of PM2.5 were directly correlated
with barometric pressure, CO and NO2 concentrations,
inversely correlated with O3 and temperature, and unre-
lated to relative humidity. Average daily concentrations of
PM10–2.5 were positively correlated with NO2, tempera-
ture, and to a lesser extent with O3, inversely correlated
with relative humidity, and not correlated with CO. NO2
concentrations were neither correlated with CO, nor with
O3. Daily mean levels of CO and O3 showed a strong neg-
ative correlation.
Correlations between ambient concentrations of PM2.5
and each metal and between metals were also examined
(data not shown). PM2.5 daily means were highly corre-
lated with Zn, Cd and Pb levels (ρ = 0.778, 0.714 and
0.694 respectively), moderately correlated with Cr, Pt, Ni
and Fe (ρ = 0.565, 0.491, 0.475 and 0.463 respectively),
and not correlated with vanadium concentrations (ρ =
0.151). Fe concentrations were scarcely correlated with
both Zn and Pb (ρ = 0.318 and 0.328), and moderately
correlated with Pt (ρ = 0.564). Pt was scarcely correlated
with Zn and Pb (ρ = 0.299 and 0.421). Zn and Pb concen-
trations were moderately correlated (ρ = 0.663).
Daily indoor concentrations of PM2.5 (averages of 24 h
samples collected at the homes of three subjects per sur-
vey) were highly correlated with average ambient PM2.5 (ρ
= 0.81, p < 0.01). A reverse PM2.5 indoor/outdoor ratio
was evident in the two seasons. Concordance was higher
during the winter survey (ρ = 0.91, p < 0.01) than in
spring (ρ = 0.59, p = 0.01), apparently due to a greater
daily variability of ambient PM2.5 concentrations in winter
COPD panel: changes in FVC per interquartile increase of selected metals from PM2.5 samples during the previous 24, 48 or 72  hours* Figure 2
COPD panel: changes in FVC per interquartile increase of selected metals from PM2.5 samples during the pre-
vious 24, 48 or 72 hours* *Regression coefficients β (dots) and 95% confidence intervals (bars) from GEE models for panel 
data controlling for repeated individual observations, temperature, relative humidity, and day of the week, representing 
changes in FVC (% of predicted) per interquartile range increase of metal concentration (see Table 2 for the IQR values).Environmental Health: A Global Access Science Source 2006, 5:11 http://www.ehjournal.net/content/5/1/11
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than in spring, and not to home-specific characteristics
(Figure 1).
Lung function
We observed a negative association between ambient
PM2.5 and PM10 and respiratory function (FVC and FEV1)
in the COPD panel (Table 4). The effect on FVC was evi-
dent both at a short lag (24 h) and in relation to cumula-
tive exposures over the previous 24 and 48 hours. The
effect on FEV1 appeared only when 72 hours of exposure
were accumulated. A FEV1 reduction was also seen with
increasing NO2 concentrations during the previous 24 and
48 hours. In the asthmatic panel, we observed decreasing
values of FEV1 related to cumulative exposure to NO2 con-
centrations during the preceding 24, 48, and 72 hours
(Table  4). No association between respiratory function
indices and average concentrations of any of the pollutants
(neither at various lags, nor as cumulative exposure over
48 or 72 h) was observed among IHD patients (Table 4).
In the COPD panel, Zn concentrations were associated
with FVC and FEV1 decrements at single 24 h lag and at
cumulative 48 h and 72 h lags (Figures 2 and 3). The asso-
ciations were similar in size but less consistent for Fe and
Ni. No statistically significant negative association
between concentrations of metals and lung function indi-
ces was observed in the asthmatic and IHD panels (data
not shown).
In the group of asthmatics, a total of 107 measurements
of NO concentrations in exhaled breath were performed.
Overall, there was no clear association of the various pol-
lutants with this biological marker of inflammation.
Discussion
This study suggests an effect of fine particles on lung func-
tion of COPD patients. The metallic content of PM2.5
seems to be of importance, given the observed negative
COPD panel: changes in FEV1 per interquartile increase of selected metals from PM2.5 samples during the previous 24, 48 or 72  hours* Figure 3
COPD panel: changes in FEV1 per interquartile increase of selected metals from PM2.5 samples during the pre-
vious 24, 48 or 72 hours* *Regression coefficients β (dots) and 95% confidence intervals (bars) from GEE models for panel 
data controlling for repeated individual observations, temperature, relative humidity, and day of the week, representing 
changes in FEV1 (% of predicted) per interquartile range increase of metal concentration (see Table 2 for the IQR values).Environmental Health: A Global Access Science Source 2006, 5:11 http://www.ehjournal.net/content/5/1/11
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effects of Zn, Fe and Ni concentrations on lung function
indices. NO2 also was associated with FEV1 decrements
among COPD cases. On the other hand, no effects of
PM2.5 were found among asthmatics, whose respiratory
function seemed to be negatively influenced by ambient
NO2 concentrations. No pollutant-related lung function
changes were observed among IHD subjects, with no pre-
existing lung impairment.
We acknowledge several limitations of the study. Lack of
personal exposure measurements is an important short-
coming. Lifestyles and housing conditions among our
study subjects were not homogenous, and we cannot
expect outdoor PM2.5 concentrations in our study to be a
perfect indicator of personal exposure variability, as it was
reported among elderly subjects residing in a retirement
facility [36,37]. However, the good correlation we
observed between day-to-day variations in average out-
door and indoor PM2.5 should mitigate the possibility that
findings among COPD patients are entirely due to errors
in estimating personal exposure variability. Moreover,
despite the high number of repeated observations per sub-
ject, the reduced number of patients in each diagnostic
category gives a low power to the study, thus we cannot
exclude the possibility that small effects were not detected
because of the reduced sample size. Last, the present study
shares with other studies of air pollution related health
effects the drawback of multiple statistical testing.
There are however strengths of the study that are worth
underlining. They include: (i) supervised lung function
tests; (ii) many repeated observations per patient, which
allowed accounting for within-subject variability; (iii) a
variety of measured urban pollutants, including fine par-
ticles, coarse particles and transition metals. Furthermore,
in the present study no association between respiratory
function indices and average ambient concentrations of
any pollutants was observed among IHD cases, whereas
effects of the fine fraction of ambient particulate on lung
function among COPD subjects were detected, which had
a strong a priori hypothesis. In the light of such results, it
seem less likely that the associations observed among
COPD and asthmatic patients are chance findings due to
the great number of relationships examined.
After considering validity issues, it is worth noting the
results of other published works. To our knowledge, only
two studies have evaluated lung function by supervised
spirometry in relation to daily variation in air pollution
among adults with COPD. In the panel study of Pope and
Kanner [25], based on 2 repeated observations of 251
smokers with mild to moderate COPD, a 10 µg/m3
increase in PM10 was associated with an average decrease
in FEV1 equal to approximately 0.2%. Brauer et al. [26], in
their panel study of 16 COPD cases with moderate airway
obstruction (FEV1 at baseline ≥ 0.75 l) observed a non-sig-
nificant 1.1% decrease of FEV1 for 10 µg/m3 increase in
ambient PM2.5. In four other studies [19-22], possible pol-
lution-related effects on pulmonary function in COPD
Table 4: Variations in respiratory function per unit increase of air pollutant concentrations in the three panels
PM2.5 PM10–2.5 PM10 NO2 CO O3
Pollutant 
increase
10 µg/m3 10 µg/m3 10 µg/m3 10 µg/m3 1 mg/m3 10 µg/m3
Panel Outcome Time β * SE (β)p β SE  (β)p β SE  (β)p β SE  (β)p β SE  (β)p β SE (β)p
COPD 24 h† -0.80 0.36 0.027 -1.32 1.06 0.210 -0.66 0.30 0.027 -0.72 0.49 0.139 -0.14 0.15 0.353 0.01 0.57 0.983
FVC (%) 48 h‡ -0.89 0.41 0.031 -1.46 1.31 0.265 -0.75 0.35 0.032 -0.43 0.58 0.463 -0.13 0.18 0.497 0.18 0.65 0.783
72 h§ -1.10 0.55 0.044 -1.38 1.53 0.367 -0.94 0.47 0.045 -0.10 0.70 0.886 0.15 0.23 0.508 -0.03 0.86 0.977
24 h† -0.47 0.33 0.149 -0.59 0.95 0.532 -0.37 0.27 0.167 -1.16 0.41 0.005 -0.05 0.13 0.725 -0.20 0.50 0.687
FEV1(%) 48 h‡ -0.69 0.37 0.061 -1.01 1.19 0.396 -0.58 0.31 0.067 -1.38 0.49 0.005 -0.12 0.16 0.467 0.31 0.56 0.578
72 h§ -1.06 0.50 0.032 -0.90 1.42 0.524 -0.87 0.43 0.040 -0.94 0.60 0.117 -0.03 0.20 0.900 0.68 0.74 0.363
Asthma 24 h† -0.14 0.29 0.617 -0.17 0.75 0.822 -0.12 0.24 0.621 -0.53 0.31 0.081 0.02 0.12 0.842 -0.33 0.41 0.416
FVC (%) 48 h‡ -0.07 0.33 0.825 -0.36 0.91 0.695 -0.09 0.29 0.750 -0.59 0.32 0.065 -0.001 0.13 0.995 0.02 0.42 0.957
72 h§ -0.06 0.39 0.886 -0.24 1.07 0.824 -0.08 0.36 0.836 -0.54 0.37 0.149 -0.06 0.16 0.700 0.14 0.50 0.782
24 h† -0.30 0.34 0.372 -0.67 0.89 0.448 -0.28 0.28 0.317 -1.10 0.35 0.002 -0.05 0.14 0.704 -0.41 0.50 0.421
FEV1(%) 48 h‡ -0.36 0.39 0.347 -1.19 1.07 0.265 -0.40 0.34 0.239 -1.28 0.37 0.001 -0.16 0.15 0.292 -0.01 0.51 0.983
72 h§ -0.40 0.46 0.384 -0.51 1.26 0.689 -0.40 0.43 0.351 -1.17 0.44 0.007 -0.28 0.18 0.126 0.46 0.60 0.449
IHD 24 h† 0.37 0.26 0.164 0.37 0.73 0.617 0.28 0.22 0.198 0.15 0.29 0.612 0.176 0.101 0.081 0.58 0.33 0.077
FVC (%) 48 h‡ 0.51 0.29 0.082 -0.25 0.88 0.779 0.35 0.25 0.160 -0.06 0.37 0.868 0.132 0.120 0.271 0.36 0.42 0.392
72 h§ 0.73 0.40 0.069 0.67 1.04 0.519 0.59 0.34 0.079 0.36 0.47 0.440 0.132 0.165 0.425 0.08 0.60 0.898
24 h† 0.43 0.33 0.192 0.25 0.86 0.770 0.32 0.27 0.240 -0.24 0.36 0.513 0.204 0.120 0.088 0.57 0.39 0.144
FEV1(%) 48 h‡ 0.55 0.34 0.106 -0.23 1.02 0.818 0.38 0.29 0.193 0.00 0.44 0.994 0.114 0.142 0.420 0.53 0.50 0.288
72 h§ 0.66 0.47 0.157 0.18 1.19 0.877 0.49 0.39 0.214 0.21 0.56 0.710 0.159 0.194 0.412 0.65 0.70 0.354
*Regression coefficient from GEE models for panel data controlling for repeated individual observations, temperature, relative humidity, and day of the week (COPD and IHD 
panels) or β-2 stimulant inhalation (asthma panel), representing the change in lung function index (% of predicted) per unit increase of pollutant concentration.
†Concentration during the previous 24 hours.
‡Average concentration over the previous 48 hours.
§Average concentration over the previous 72 h.Environmental Health: A Global Access Science Source 2006, 5:11 http://www.ehjournal.net/content/5/1/11
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cases were examined by unsupervised measurements of
peak expiratory flow (PEF). To our knowledge, our study
is the first that was able to document a specific role of fine
particles on lung function of COPD patients.
PM-related exacerbation of chronic obstructive lung dis-
ease may be sustained by multiple direct and indirect
mechanisms [5,38,39]. There is empirical evidence and
experimental support for direct damages to the respiratory
mucosa (increased permeability and reduced mucociliar
activity), for oxidative damage, and for secondary toxic
effects mediated by pro-inflammatory cytokines. Relative
to healthy subjects, patients with moderate-to-severe air-
way obstruction receive an increased dose from ultra fine
particle exposure [40]. Transition metals [7,8], as well as
ultra fine particles [6], may induce oxidative stress and
inflammatory response. We are not aware of previous
panel studies of adult COPD cases examining pulmonary
function changes in relation to the metallic content of air-
borne PM. The exploratory analyses presented in this
paper suggest that metals from inhaled particulate have a
biological effect on pulmonary function. The results on
Zn and Fe are of specific interest. Both metals present in
the fine fraction are likely to be traffic related as they orig-
inate from engine oils, brake, engine, exhaust systems and
tire wear [41]. They have a high water solubility which has
been directly related to oxidative damage [42].
Results from the asthmatic panel suggest a negative influ-
ence of NO2 on FEV1, but no effect of fine particles. Our
finding that NO2 is related to lung function decrements
both among COPD and asthma patients is of interest. It is
difficult to believe that NO2 per se is responsible of the
observed effects, given its low intrinsic toxicity. It has been
suggested, however, that NO2 may be considered a very
good marker of the combustion mixture from traffic
sources, in particular of ultra fine particles [43].
No effect of O3 concentrations on the respiratory function
of asthmatics was detected, even when the analysis was
restricted to the spring survey. The latter finding could be
explained by the relatively good clinical conditions of the
asthmatics included in the study (all in the mild intermit-
tent stage), the relatively low levels of O3 recorded during
the study period, or simply lack of power. Although many
panel studies of adult asthmatics have reported associa-
tions between asthma symptoms and both PM and O3
[13,14], inconsistent results were observed with regard to
lung function. Moseholm and coworkers [16] found that
increased levels of SO2 and NO2 corresponded synergisti-
cally to decreased peak flow at levels above 40 µg/m3. In
the asthmatic panel studied by Taggart et al. [24], changes
in bronchial hyper-responsiveness were significantly cor-
related with 24 h mean concentrations of SO2, NO2 and
black smoke, none of the criteria air pollutants seemed to
affect FEV1, while previous-day NO2 levels were associated
with FVC decrements. Ambient PM10 concentrations neg-
atively affected PEF readings among the asthmatics fol-
lowed by Peters et al. [17], with especially strong effects
due to the number of ultra fine particles. Higgins et al.
[19] observed PEF decrements associated with SO2 and O3
among the methacolin-reactors in their panel, but no
independent effect of ambient NO2 levels. On the other
hand, among the asthmatics followed by Hiltermann et
al. [18], ambient concentrations of O3, PM10, black smoke
and NO2  were found to be associated with increased
symptom reports, but not with decreased PEF readings.
Conclusion
In conclusion our study, despite its limitations, suggests
that the short-term negative impact of exposure to rela-
tively low concentrations of air pollutants on lung func-
tion is limited to individuals with already impaired
respiratory health. The fine fraction of ambient PM seems
responsible for the observed effects among COPD cases,
with zinc and iron having a potential role. These hints
require confirmation from larger and more focused panel
studies, using appropriate methods to overcome the prob-
lem of multiple comparisons [44].
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